Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Drug Delivery Devices Market By Type Disease Distribution Channel and Region Forecast 2019-2030
Drug Delivery Devices Market size was valued at US$ 337.3 billion in 2023 and is expected to grow at a CAGR of 6.3% from 2024 to 2030. Drug Delivery Devices is defined as the kind of technique that is used for recognizing numerous diseases found in poultry. The method includes chickens, ducks, waterfowl, turkeys, and other birds. Several diseases are seen in birds, such as Avian Mycoplasmosis, Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, and others. The global market provides a detailed overview of the market size, and that can be segmented by type, by disease, and by Distribution channel. By type, the market growth has been segmented into PCR Test Kits, ELISA Test Kits, and Others.
The Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment is likely to be the largest and fastest-growing segment in terms of type. The rise of this segment is mainly due to the advantages it offers. This test provides greater specificity and sensitivity, cost-effectiveness, and precision. Based on Disease, the market is segmented into Bacterial diseases, Viral diseases, Parasitic diseases, Mycoses and Mycotoxicosis, and Neoplastic Diseases. Among these, the viral disease segment is expected to have the fastest-growing market during the forecast period 2022-2028.
Domestic birds are usually infected by the low pathogenic kind producing respiratory diseases, failure in egg production, and clinical infections. In a few scenarios, high pathogenic (HPAI) forms may also contaminate domestic flocks. The high pathogenic type sources systemic infections and even mortality. Based on the Distribution channel, the market is segmented into Veterinary Hospitals, Veterinary Clinics, and Others. The Veterinary hospitals segment is expected to have a significant share in 2021. The rise of this segment is mainly because it offers consultation, diagnostic testing, and extension services for backyard and commercial poultry producers. These hospitals provide testing plans to cover one pet chicken, minor flocks, or commercial producers.
Study Period
2024-2030Base Year
2023CAGR
6.3%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
The outbreak of poultry diseases are anticipated to propel the market growth over the forecast years. Moreover, the increasing incidence of zoonotic diseases in the upcoming years, an upsurge in demand for poultry-derived food items, as well as the beginning of animal health information portals in advanced nations are burgeoning the market growth over the forecast years.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 337.3 billion |
Market CAGR |
6.3% |
By Type |
|
By Disease |
|
By Distribution Channel |
|
By Region |
|
Download Free Sample Report
The drug delivery devices market size was valued at US$ 337.3 billion in 2023 and is projected to grow at a CAGR of 6.3% from 2024 -2030
Becton Dickinson and Company (U.S.), Hoffmann La Roche Ltd. (Switzerland), Smiths medical, Inc. (U.S.), Braun Melsungen AG (Germany), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Sanofi S.A. (France), Abbott Laboratories (U.S.), Novartis AG (Switzerland), Eli Lilly and company (U.S.)
North America is the fastest-growing region in the market
1. Executive Summary |
2. Global Drug Delivery Devices Market Introduction |
2.1.Global Drug Delivery Devices Market - Taxonomy |
2.2.Global Drug Delivery Devices Market - Definitions |
2.2.1.Type |
2.2.2.Disease |
2.2.3.Distribution Channel |
2.2.4.Region |
3. Global Drug Delivery Devices Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Drug Delivery Devices Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Drug Delivery Devices Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
5.1. PCR Test Kits |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. ELISA Test Kits |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others. |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6. Global Drug Delivery Devices Market By Disease, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
6.1. Bacterial diseases |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Viral diseases |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Parasitic diseases |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Mycoses and Mycotoxicosis |
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Neoplastic Diseases |
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Drug Delivery Devices Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
7.1. Veterinary Hospitals |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Veterinary Clinics |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others. |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8. Global Drug Delivery Devices Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Drug Delivery Devices Market,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.PCR Test Kits |
9.1.2.ELISA Test Kits |
9.1.3.Others. |
9.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Bacterial diseases |
9.2.2.Viral diseases |
9.2.3.Parasitic diseases |
9.2.4.Mycoses and Mycotoxicosis |
9.2.5.Neoplastic Diseases |
9.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Veterinary Hospitals |
9.3.2.Veterinary Clinics |
9.3.3.Others. |
9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.PCR Test Kits |
10.1.2.ELISA Test Kits |
10.1.3.Others. |
10.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Bacterial diseases |
10.2.2.Viral diseases |
10.2.3.Parasitic diseases |
10.2.4.Mycoses and Mycotoxicosis |
10.2.5.Neoplastic Diseases |
10.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Veterinary Hospitals |
10.3.2.Veterinary Clinics |
10.3.3.Others. |
10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.PCR Test Kits |
11.1.2.ELISA Test Kits |
11.1.3.Others. |
11.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Bacterial diseases |
11.2.2.Viral diseases |
11.2.3.Parasitic diseases |
11.2.4.Mycoses and Mycotoxicosis |
11.2.5.Neoplastic Diseases |
11.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Veterinary Hospitals |
11.3.2.Veterinary Clinics |
11.3.3.Others. |
11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Drug Delivery Devices Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.PCR Test Kits |
12.1.2.ELISA Test Kits |
12.1.3.Others. |
12.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Bacterial diseases |
12.2.2.Viral diseases |
12.2.3.Parasitic diseases |
12.2.4.Mycoses and Mycotoxicosis |
12.2.5.Neoplastic Diseases |
12.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Veterinary Hospitals |
12.3.2.Veterinary Clinics |
12.3.3.Others. |
12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Drug Delivery Devices Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.PCR Test Kits |
13.1.2.ELISA Test Kits |
13.1.3.Others. |
13.2. Disease Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Bacterial diseases |
13.2.2.Viral diseases |
13.2.3.Parasitic diseases |
13.2.4.Mycoses and Mycotoxicosis |
13.2.5.Neoplastic Diseases |
13.3. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Veterinary Hospitals |
13.3.2.Veterinary Clinics |
13.3.3.Others. |
13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Becton Dickinson and Company (U.S.) |
14.2.2.Hoffmann La Roche Ltd. (Switzerland) |
14.2.3.Smiths medical, Inc. (U.S.) |
14.2.4.Braun Melsungen AG (Germany) |
14.2.5.Pfizer, Inc. (U.S.) |
14.2.6.Merck & Co., Inc. (U.S.) |
14.2.7.Sanofi S.A. (France) |
14.2.8.Abbott Laboratories (U.S.) |
14.2.9.Novartis AG (Switzerland) |
14.2.10. Eli Lilly and company (U.S.) |
15. Research Methodology |
16. Appendix and Abbreviations |
Key Market Players